Home›People›Antony Loebel
AL

Antony Loebel

Chief Medical Officer at Seaport Therapeutics.

ExecutivePublic company
Updated Oct 27, 2026·Latest SEC filing May 4, 2026·Suggest an edit

About Antony Loebel

Antony Loebel is a chief medical officer at Seaport Therapeutics.

Antony Loebel reports to the SEC as a director or officer of 2 public companies, including Quantum-Si (QSI).

Antony Loebel first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Antony Loebel in the role, so the role may have started earlier or lasted longer.

Seaport Therapeutics, Inc.
Chief Medical Officer
2024 – 2026 · Public company (SPTX)
Quantum-Si Inc
Director
2020 · Public company (QSI)

Key Colleagues at Startups

The people Antony Loebel works with at each company, as listed on that company's latest Form D.

Seaport Therapeutics, Inc. · Form D, Oct 31, 2024
JH
James Healy
Director
MC
Michael Chen
Executive officer
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
DW
EG
Eric Green
Executive officer
RN
SP
Steven Paul
Director
DT
EE
Eric Elenko
Director
JP
Jason Pitts
Director

Sources

  1. SECSeaport Therapeutics, Inc. Form D, filed Oct 31, 2024
  2. SECForms 3, 4 and 5 filed by Antony Loebel (SEC filer 1818770)